Dr Melanie Goward on life sciences in Wales

Dr Melanie Goward, Senior Investment Executive of Finance Wales considers what makes Wales such a hot-bed of opportunity for high-quality life sciences companies.

Whether its medical devices, diagnostics, pharmaceuticals or healthcare technology, life sciences investments are a significant and growing part of Finance Wales’ portfolio.

In total they now account for over 60% of the value of our early stage technology investments.

Supporting the sector

As well as the backing of a strong investor like Finance Wales, there’s also a great deal on offer for life science companies establishing in Wales:

  • World-class academic work
  • Facilitated access to the NHS
  • High-quality facilities
  • Range of expertise and people skills
  • Government financial support

Funding cycles

The life sciences sector is highly regulated and gaining regulatory approval can be a timely and uncertain process.

Our investments match typical sector funding cycles and we can invest at early proof-of-concept and pre-revenue stages through to development and product launch.

Increased fire-power

We can invest up to £1 million initially and then potentially follow its investments with more significant sums. Additional fire-power comes from our ability to co-invest with private and institutional investors and as well as tie-up Fusion IP which has successfully invested £4.2 million in seven spinouts.

An extensive network also offers benefits ranging from sign-posting the right regulatory advice to strengthening management teams. 

As a supportive long-term investor our goal is to ensure we do our utmost to help the companies we invest in.

New Welsh Life Science Investment Fund

With the recent announcement of a £100 million Welsh Science Investment Fund there's a lot going on in Wales to cement the future of its life sciences sector.